Literature DB >> 7014348

Detection of liver IgG Fc receptors using soluble immune complexes of peroxidase-antiperoxidase. II. Detection in liver tissue from mice with D-galactosamine-induced hepatitis.

T Shinohara.   

Abstract

The presence of liver IgG Fc receptor sites was demonstrated in the liver tissue from C-57 black mice with D-Galactosamine (GalN)-induced hepatitis by the localization of soluble immune complexes of peroxidase-antiperoxidase (PAP). Cryostat sections of liver tissues were incubated with the complexes and the peroxidase activity was revealed histochemically. In the normal liver tissue, PAP were localized on the Kupffer cells, some of the sinusoidal walls, and the liver cell membrane mainly at the side of the sinusoid. Twenty-four hours after single administration of GalN (1,500 mg/kg body weight), positive PAP reaction was mainly observed on the membrane surface of infiltrating cells in the area of hepatocellular focal necrosis, and faintly observed on the degenerative hepatic cell membrane and the sinusoidal walls. After 48 hours, these features became more remarkable, especially at the sites with severe necrotic lesions. After 72 hours, the positive reaction on the regenerative hepatic cell membranes again became distinct. At the chronic stage 13 weeks after repeated administrations of GalN and Freund's complete adjuvant, a strong positive reaction was found on swollen and multiplied Kupffer cells, and a faint one found on the liver cell membrane, especially at the periphery of the lobules; moreover, many PAP-positive infiltrated cells were found in the area of piecemeal necrosis. The relationship between liver IgG Fc receptors and the severity of liver cell necrosis is discussed.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7014348     DOI: 10.1007/bf02774389

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  20 in total

1.  Differentiation between B cells, T cells, and histiocytes in melanocytic lesions: primary and metastatic melanoma and halo and giant pigmented nevi.

Authors:  R L Edelson; V J Hearing; A L Dellon; M Frank; E K Edelson; I Green
Journal:  Clin Immunol Immunopathol       Date:  1975-11

2.  Tissue localization of C1q in HBs antigen positive liver disease patients by direct immunofluorescent technique.

Authors:  T Tsuji; K Naito; K Araki; K Onoue; H Nozaki; H Nagashima
Journal:  Acta Med Okayama       Date:  1977-02       Impact factor: 0.892

3.  Identification of cells infiltrating the minor salivary glands in patients with Sjögren's syndrome.

Authors:  T M Chused; J A Hardin; M M Frank; I Green
Journal:  J Immunol       Date:  1974-02       Impact factor: 5.422

4.  Similarities of Fc receptors in human malignant tissue and normal lymphoid tissue.

Authors:  O Tonder; P A Morse; L J Humphrey
Journal:  J Immunol       Date:  1974-10       Impact factor: 5.422

5.  Experimental hepatitis induced by D-galactosamine.

Authors:  D Keppler; R Lesch; W Reutter; K Decker
Journal:  Exp Mol Pathol       Date:  1968-10       Impact factor: 3.362

6.  Tissue localization of two populations of human lymphocytes distinguished by membrane receptors.

Authors:  N P Silveira; N F Mendes; M E Tolnai
Journal:  J Immunol       Date:  1972-05       Impact factor: 5.422

7.  The trapping of uridine phosphates by D-galactosamine. D-glucosamine, and 2-deoxy-D-galactose. A study on the mechanism of galactosamine hepatitis.

Authors:  D O Keppler; J F Rudigier; E Bischoff; K F Decker
Journal:  Eur J Biochem       Date:  1970-12

8.  Detection of Fc-receptor on human renal glomerulus.

Authors:  Y Mizoguchi; K Tanimoto; S Yoshinoya; T Mitamura; T Morito; H Nakai; Y Horiuchi; T Umeda
Journal:  Clin Immunol Immunopathol       Date:  1978-06

9.  Detection of liver IgG Fc receptors using soluble immune complexes of peroxidase-antiperoxidase. I. Detection in liver tissue from patients with liver diseases.

Authors:  T Shinohara
Journal:  Gastroenterol Jpn       Date:  1981

10.  Receptor specific clearance by the reticuloendothelial system in chronic liver diseases. Demonstration of defective C3b-specific clearance in primary biliary cirrhosis.

Authors:  C J Jaffe; J M Vierling; E A Jones; T J Lawley; M M Frank
Journal:  J Clin Invest       Date:  1978-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.